Power Heart Consortium, a Korean private equity group, invested in Cleveland Heart, which is a joint venture between Cleveland Clinic and medical technology company TransWorld Medical Devices.
Cleveland Heart, a spin-off company from US-based medical research institute Cleveland Clinic’s Innovations corporate venturing unit, has raised $30m in its series A round to develop and test an artificial heart.
Power Heart Consortium, a Korean private equity group, invested in Cleveland Heart, which is a joint venture between Cleveland Clinic and medical technology company TransWorld Medical Devices.
The $30m is the largest amount that a Cleveland Clinic Innovations spin-off has received from a single investor, while Cleveland Clinic remains…
